DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 77 filers reported holding DYNE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $218,624 | -40.2% | 24,400 | -24.9% | 0.00% | 0.0% |
| Q2 2023 | $365,625 | -80.0% | 32,500 | -79.6% | 0.00% | -80.0% |
| Q1 2023 | $1,831,530 | +1.7% | 158,987 | +2.3% | 0.01% | -16.7% |
| Q4 2022 | $1,800,495 | +733.6% | 155,349 | +812.5% | 0.01% | +500.0% |
| Q3 2022 | $216,000 | -16.3% | 17,024 | -36.3% | 0.00% | 0.0% |
| Q1 2022 | $258,000 | -83.0% | 26,722 | -79.1% | 0.00% | -66.7% |
| Q4 2021 | $1,519,000 | -17.4% | 127,729 | +12.8% | 0.00% | -25.0% |
| Q3 2021 | $1,838,000 | +355.0% | 113,204 | +335.4% | 0.00% | +300.0% |
| Q1 2021 | $404,000 | – | 26,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,960,046 | $35,195,000 | 13.16% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $58,871,000 | 12.72% |
| Atlas Venture Life Science Advisors, LLC | 8,934,902 | $106,236,000 | 9.76% |
| Logos Global Management LP | 3,234,392 | $38,457,000 | 3.97% |
| GREAT POINT PARTNERS LLC | 845,000 | $10,047,000 | 2.23% |
| Deep Track Capital, LP | 2,292,250 | $27,255,000 | 1.92% |
| Octagon Capital Advisors LP | 583,649 | $6,940,000 | 1.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 476,000 | $5,641,000 | 1.26% |
| COMMODORE CAPITAL LP | 305,125 | $3,628,000 | 0.84% |
| RA Capital Management | 2,805,045 | $33,352,000 | 0.59% |